scispace - formally typeset
J

Javier Gutierrez-Achury

Researcher at Wellcome Trust Sanger Institute

Publications -  29
Citations -  3287

Javier Gutierrez-Achury is an academic researcher from Wellcome Trust Sanger Institute. The author has contributed to research in topics: Genome-wide association study & Human leukocyte antigen. The author has an hindex of 19, co-authored 29 publications receiving 2669 citations. Previous affiliations of Javier Gutierrez-Achury include University of Groningen & Wellcome Trust.

Papers
More filters
Journal ArticleDOI

Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease

TL;DR: This work identified 25 new susceptibility loci, 3 of which contain integrin genes that encode proteins in pathways that have been identified as important therapeutic targets in inflammatory bowel disease and identified 3 associated variants that are correlated with expression changes in response to immune stimulus at two of these genes.
Journal ArticleDOI

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

Jimmy Z. Liu, +95 more
- 01 Jun 2013 - 
TL;DR: This analysis compared 3,789 PSC cases of European ancestry to 25,079 population controls across 130,422 SNPs genotyped using the Immunochip to identify 12 genome-wide significant associations outside the human leukocyte antigen (HLA) complex, 9 of which were new, increasing the number of known PSC risk loci to 16.

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

Abstract: Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown etiology leading to fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation. We compared 3,789 PSC cases of European ancestry to 25,079 population controls across 130,422 SNPs genotyped using the Immunochip. We identified 12 genome-wide significant associations outside the human leukocyte antigen (HLA) complex, 9 of which were new, increasing the number of known PSC risk loci to 16. Despite comorbidity with inflammatory bowel disease (IBD) in 72% of the cases, 6 of the 12 loci showed significantly stronger association with PSC than with IBD, suggesting overlapping yet distinct genetic architectures for these two diseases. We incorporated association statistics from 7 diseases clinically occurring with PSC in the analysis and found suggestive evidence for 33 additional pleiotropic PSC risk loci. Together with network analyses, these findings add to the genetic risk map of PSC and expand on the relationship between PSC and other immune-mediated diseases.
Journal ArticleDOI

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

Sun-Gou Ji, +77 more
- 01 Feb 2017 - 
TL;DR: This study undertook the largest genome-wide association study of PSC and identified four new genome- wide significant loci, with the most associated SNP at one locus predicted to cause nonstop-mediated mRNA decay and lower expression of UBASH3A.